Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967069 · ClinicalTrials.gov registry record · Phase 3
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis
A Phase 3 study, sponsored by Primus Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 277
- Enrollment target
NCT01967069: Completed Phase 3 study, sponsored by Primus Pharmaceuticals.
NCT01967069 is a Phase 3 study that has completed, run by Primus Pharmaceuticals. The registered enrollment target is 277 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01967069, a Phase 3 study, has completed, sponsored by Primus Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 277 participants
- Enrollment target
Study Summary
The objectives of this study are to compare the efficacy and safety of DFD01 Spray to Vehicle Spray for topical treatment of moderate plaque psoriasis
Primary Outcome
IGA of clear or almost clear
Interventions
- DRUG DFD01 Spray
- DRUG Vehicle Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
What the finished NCT01967069 record still lists
NCT01967069 is an interventional study that assigns participants to a tested intervention. The registered 277 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which DFD01 Spray is the first listed.
NCT01967069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01967069 about?
NCT01967069 is a clinical study titled "A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis". The objectives of this study are to compare the efficacy and safety of DFD01 Spray to Vehicle Spray for topical treatment of moderate plaque psoriasis
What is the current status of trial NCT01967069?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 277 participants. The study started on 2013-11. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01967069?
The interventions under investigation include: DFD01 Spray (DRUG), Vehicle Spray (DRUG).
Who is sponsoring clinical trial NCT01967069?
This trial is sponsored by Primus Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01967069's enrollment target sits among peer trials
277 1202nd of 2000 higher than 799 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05818683 · 277 participants · Phase 1
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
- NCT06789913 · 277 participants · Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia